Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Intrauterine growth restriction, preterm birth and risk of end-stage renal disease during the first 50 years of life.

Gjerde A, Lillås BS, Marti HP, Reisæter AV, Vikse BE.

Nephrol Dial Transplant. 2020 Feb 10. pii: gfaa001. doi: 10.1093/ndt/gfaa001. [Epub ahead of print]

PMID:
32040151
2.

Kidney transplantation: an attractive and cost-effective alternative for older patients? A cost-utility study.

Heldal K, Midtvedt K, Lønning K, Iversen T, Hernæs KH, Tsarpali V, Reisæter AV, Bernklev T.

Clin Kidney J. 2019 Feb 28;12(6):888-894. doi: 10.1093/ckj/sfz018. eCollection 2019 Dec.

3.

Sex Differences in Kidney Replacement Therapy Initiation and Maintenance.

Antlanger M, Noordzij M, van de Luijtgaarden M, Carrero JJ, Palsson R, Finne P, Hemmelder MH, Aresté-Fosalba N, Reisæter AV, Cases A, Traynor JP, Kramar R, Massy Z, Jager KJ, Hecking M; ERA-EDTA Registry.

Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1616-1625. doi: 10.2215/CJN.04400419. Epub 2019 Oct 24.

PMID:
31649071
4.

Organ donation for migrants and ethnic minorities.

Bhopal A, Wium C, Reisæter AV, Bhala N, Kumar B.

Tidsskr Nor Laegeforen. 2019 Sep 19;139(13). doi: 10.4045/tidsskr.19.0406. Print 2019 Sep 24. Norwegian, English. No abstract available.

5.

Contraceptive Choices and Counseling in Norwegian Female Renal Transplant Recipients.

Eide IA, Rashidi F, Lønning K, Oldereid NB, Reisæter AV, Åsberg A, Midtvedt K.

Transplant Proc. 2019 Mar;51(2):470-474. doi: 10.1016/j.transproceed.2019.01.068. Epub 2019 Jan 28.

PMID:
30879570
6.

Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study.

Thorsen IS, Bleskestad IH, Åsberg A, Hartmann A, Skadberg Ø, Brede C, Ueland T, Pasch A, Reisaeter AV, Gøransson LG.

Clin Transplant. 2019 May;33(5):e13517. doi: 10.1111/ctr.13517. Epub 2019 Mar 28.

PMID:
30844090
7.

Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial.

Gustavsen MT, Midtvedt K, Lønning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Åsberg A.

Transpl Int. 2019 Jun;32(6):614-625. doi: 10.1111/tri.13412. Epub 2019 Mar 6.

PMID:
30770608
8.

International comparison of trends in patients commencing renal replacement therapy by primary renal disease.

Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, Heaf JG, Hemmelder MH, Martínez-Castelao A, de Meester J, Palsson R, Prischl FC, Segelmark M, Traynor JP, Santamaria R, Reisaeter AV, Massy ZA, Jager KJ.

Nephrology (Carlton). 2019 Oct;24(10):1064-1076. doi: 10.1111/nep.13531. Epub 2019 Apr 29.

PMID:
30456883
9.

High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study.

Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strøm EH, Holdaas H, Hartmann A, Åsberg A.

Transpl Int. 2019 Mar;32(3):257-269. doi: 10.1111/tri.13356. Epub 2018 Oct 15.

10.

Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.

Hruskova Z, Pippias M, Stel VS, Abad-Díez JM, Benítez Sánchez M, Caskey FJ, Collart F, De Meester J, Finne P, Heaf JG, Magaz A, Palsson R, Reisæter AV, Salama AD, Segelmark M, Traynor JP, Massy ZA, Jager KJ, Tesar V.

Am J Kidney Dis. 2019 Feb;73(2):184-193. doi: 10.1053/j.ajkd.2018.05.016. Epub 2018 Aug 16.

PMID:
30122544
11.

Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation.

Lønning K, Heldal K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisæter AV, Line PD, Hartmann A, Midtvedt K.

Transplant Direct. 2018 Mar 1;4(4):e351. doi: 10.1097/TXD.0000000000000770. eCollection 2018 Apr.

12.

The Effect of Pregnancy on the Long-term Risk of Graft Loss, Cardiovascular Disease, and Death in Kidney Transplanted Women in Norway: A Retrospective Cohort Study.

Majak GB, Reisæter AV, Weedon-Fekjær H, Henriksen T, Michelsen TM.

Transplantation. 2018 Sep;102(9):e391-e396. doi: 10.1097/TP.0000000000002167.

PMID:
29528968
13.

Implementation of a new patient education programme for renal transplant recipients.

Urstad KH, Wahl AK, Engebretsen E, Larsen MH, Vidnes TK, Stenwig AGK, Simensen ØW, Nordli A, Reisaeter AV, Andersen MH.

J Ren Care. 2018 Jun;44(2):106-114. doi: 10.1111/jorc.12236. Epub 2018 Feb 19.

PMID:
29460501
14.

Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort study.

Heldal K, Midtvedt K, Hartmann A, Reisaeter AV, Heldal TF, Bergan S, Salvador CL, Åsberg A.

Transpl Int. 2018 Jun;31(6):629-638. doi: 10.1111/tri.13137. Epub 2018 Mar 14.

15.

Access to kidney transplantation in European adults aged 75-84 years and related outcomes: an analysis of the European Renal Association-European Dialysis and Transplant Association Registry.

Pippias M, Stel VS, Kramer A, Abad Diez JM, Aresté-Fosalba N, Ayav C, Buturovic J, Caskey FJ, Collart F, Couchoud C, De Meester J, Heaf JG, Helanterä I, Hemmelder MH, Kostopoulou M, Noordzij M, Pascual J, Palsson R, Reisaeter AV, Traynor JP, Massy Z, Jager KJ.

Transpl Int. 2018 May;31(5):540-553. doi: 10.1111/tri.13125. Epub 2018 Mar 2.

16.

Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation.

García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Reisaeter AV, Seron D.

Clin Transplant. 2018 Mar;32(3):e13196. doi: 10.1111/ctr.13196. Epub 2018 Jan 30.

PMID:
29380890
17.

Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry.

Ceretta ML, Noordzij M, Luxardo R, De Meester J, Abad Diez JM, Finne P, Heaf JG, Couchoud C, Kramar R, Collart F, Cases A, Palsson R, Reisæter AV, Rydell H, Massy ZA, Jager KJ, Kramer A.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1794-1804. doi: 10.1093/ndt/gfx355.

PMID:
29361126
18.

Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study.

Heldal TF, Ueland T, Jenssen T, Hartmann A, Reisaeter AV, Aukrust P, Michelsen A, Åsberg A.

Transpl Int. 2018 May;31(5):510-519. doi: 10.1111/tri.13116. Epub 2018 Jan 30.

19.

Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid Level.

Eide IA, Dörje C, Svensson M, Jenssen T, Hammarstrøm C, Scott H, Bjerve KS, Christensen JH, Schmidt EB, Hartmann A, Åsberg A, Reisæter AV, Reinholt FP.

J Ren Nutr. 2018 Mar;28(2):118-124. doi: 10.1053/j.jrn.2017.09.001. Epub 2017 Nov 14.

PMID:
29146138
20.

Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.

Lefaucheur C, Viglietti D, Hidalgo LG, Ratner LE, Bagnasco SM, Batal I, Aubert O, Orandi BJ, Oppenheimer F, Bestard O, Rigotti P, Reisaeter AV, Kamar N, Lebranchu Y, Duong Van Huyen JP, Bruneval P, Glotz D, Legendre C, Empana JP, Jouven X, Segev DL, Montgomery RA, Zeevi A, Halloran PF, Loupy A.

J Am Soc Nephrol. 2018 Feb;29(2):620-635. doi: 10.1681/ASN.2017050589. Epub 2017 Oct 17.

21.

Changes in health-related quality of life in older candidates waiting for kidney transplantation.

Lønning K, Midtvedt K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisaeter AV, Line PD, Hartmann A, Heldal K.

Nephrology (Carlton). 2018 Oct;23(10):948-956. doi: 10.1111/nep.13117.

PMID:
28734131
22.

Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants.

Torres IB, Reisaeter AV, Moreso F, Âsberg A, Vidal M, Garcia-Carro C, Midtvedt K, Reinholt FP, Scott H, Castellà E, Salcedo M, Dörje C, Sellarés J, Azancot MA, Perello M, Holdaas H, Serón D.

Transpl Int. 2017 Nov;30(11):1119-1131. doi: 10.1111/tri.13002. Epub 2017 Jul 27.

23.

High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation.

Egeland EJ, Robertsen I, Hermann M, Midtvedt K, Størset E, Gustavsen MT, Reisæter AV, Klaasen R, Bergan S, Holdaas H, Hartmann A, Åsberg A.

Transplantation. 2017 Aug;101(8):e273-e279. doi: 10.1097/TP.0000000000001796.

PMID:
28452920
24.

Scandiatransplant acceptable mismatch program (STAMP) a bridge to transplanting highly immunized patients.

Koefoed-Nielsen P, Weinreich I, Bengtsson M, Lauronen J, Naper C, Gäbel M, Sørensen SS, Wennberg L, Reisaeter AV, Møller BK; Nordic Kidney group and the Tissue Typing group in Scandiatransplant.

HLA. 2017 Jul;90(1):17-24. doi: 10.1111/tan.13046. Epub 2017 Apr 27.

PMID:
28449350
25.

Exposure to Mycophenolate and Fatherhood.

Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A.

Transplantation. 2017 Jul;101(7):e214-e217. doi: 10.1097/TP.0000000000001747.

26.

Preeclampsia in kidney transplanted women; Outcomes and a simple prognostic risk score system.

Majak GB, Reisæter AV, Zucknick M, Lorentzen B, Vangen S, Henriksen T, Michelsen TM.

PLoS One. 2017 Mar 20;12(3):e0173420. doi: 10.1371/journal.pone.0173420. eCollection 2017.

27.

Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.

Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisæter AV, Mjøen G, Pihlstrøm HK, Næss H, Holdaas H.

Transplantation. 2017 Oct;101(10):2599-2605. doi: 10.1097/TP.0000000000001659.

PMID:
28207636
28.

Should patients older than 65 years be offered a second kidney transplant?

Heldal K, Hartmann A, Lønning K, Leivestad T, Reisæter AV, Line PD, Holdaas H, Midtvedt K.

BMC Nephrol. 2017 Jan 11;18(1):13. doi: 10.1186/s12882-016-0426-0.

29.

Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry.

van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM, Jager KJ.

Nephrol Dial Transplant. 2017 Feb 1;32(2):348-355. doi: 10.1093/ndt/gfw392.

PMID:
28031344
30.

Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?

Lønning K, Midtvedt K, Leivestad T, Reisæter AV, Line PD, Hartmann A, Heldal K.

Transplantation. 2016 Dec;100(12):2705-2709.

31.

End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population.

Skrunes R, Svarstad E, Reisæter AV, Marti HP, Vikse BE.

PLoS One. 2016 Nov 9;11(11):e0165026. doi: 10.1371/journal.pone.0165026. eCollection 2016.

32.

Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure.

Nordheim E, Dahle DO, Syse IM, Åsberg A, Reisæter AV, Hartmann A.

Transplant Direct. 2016 Oct 25;2(11):e113. eCollection 2016 Nov.

33.

HLA Mismatch and Allograft Survival.

Mjoen G, Reisaeter AV, Dahle DO.

Transplantation. 2016 Sep;100(9):e52. doi: 10.1097/TP.0000000000001366. No abstract available.

PMID:
27399204
34.

Pregnancy outcomes following maternal kidney transplantation: a national cohort study.

Majak GB, Sandven I, Lorentzen B, Vangen S, Reisaeter AV, Henriksen T, Michelsen TM.

Acta Obstet Gynecol Scand. 2016 Oct;95(10):1153-61. doi: 10.1111/aogs.12937. Epub 2016 Jul 6.

PMID:
27288648
35.

Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.

García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV.

Transplantation. 2017 Jun;101(6):1410-1415. doi: 10.1097/TP.0000000000001216.

PMID:
27163535
36.

Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant.

Dörje C, Reisaeter AV, Dahle DO, Mjøen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP.

Clin Transplant. 2016 Jul;30(7):802-9. doi: 10.1111/ctr.12753. Epub 2016 May 18.

PMID:
27101801
37.

Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria.

Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisaeter AV, Jenssen T.

Transpl Int. 2016 May;29(5):568-78. doi: 10.1111/tri.12757. Epub 2016 Mar 9.

38.

Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience.

Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K.

Nephrology (Carlton). 2016 Oct;21(10):821-7. doi: 10.1111/nep.12738.

PMID:
26854648
39.

Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry.

Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M, Traynor JP, Reisæter AV, Caskey FJ, Jager KJ.

Transplantation. 2016 Sep;100(9):1955-62. doi: 10.1097/TP.0000000000000962.

PMID:
26588008
40.

Impact of initial dialysis modality on mortality: a propensity-matched study.

Waldum-Grevbo B, Leivestad T, Reisæter AV, Os I.

BMC Nephrol. 2015 Oct 30;16:179. doi: 10.1186/s12882-015-0175-5.

41.

Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival.

Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M.

Nephrol Dial Transplant. 2016 Jan;31(1):160-7. doi: 10.1093/ndt/gfv339. Epub 2015 Sep 25.

PMID:
26410884
42.

The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation.

Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1246-56. doi: 10.2215/CJN.11931214. Epub 2015 Jun 10.

43.

Obstetric and neonatal outcome of pregnancies fathered by males on immunosuppression after solid organ transplantation.

Morken NH, Diaz-Garcia C, Reisaeter AV, Foss A, Leivestad T, Geiran O, Hervás D, Brännström M.

Am J Transplant. 2015 Jun;15(6):1666-73. doi: 10.1111/ajt.13159. Epub 2015 Apr 13.

44.

Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies.

Sriskandarajah S, Aasarød K, Skrede S, Knoop T, Reisæter AV, Bjørneklett R.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i67-75. doi: 10.1093/ndt/gfv008. Epub 2015 Feb 17.

45.

Regional differences in renal replacement therapy in northern Norway 2000-2012.

Norum J, Leivestad T, Eriksen BO, Skår S, Fagerheim A, Reisæter AV.

Int J Circumpolar Health. 2015 Feb 10;74:24298. doi: 10.3402/ijch.v74.24298. eCollection 2015.

46.

One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts.

Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV.

Clin Transplant. 2015 Mar;29(3):268-76. doi: 10.1111/ctr.12515. Epub 2015 Feb 6.

47.

Regional differences in renal replacement therapy in northern Norway 2000-2012.

Norum J, Leivestad T, Eriksen BO, Skår S, Fagerheim A, Reisæter AV.

Int J Circumpolar Health. 2015 Jan;74(1):24298. doi: 10.3402/ijch.v74.24298.

PMID:
28417823
48.

From dialysis to transplantation: a 5-year longitudinal study on self-reported quality of life.

von der Lippe N, Waldum B, Brekke FB, Amro AA, Reisæter AV, Os I.

BMC Nephrol. 2014 Dec 2;15:191. doi: 10.1186/1471-2369-15-191.

49.

Analysis of predictive and preventive factors for de novo donor-specific antibodies in kidney transplant recipientsy--is nonadherence of importance?

Dörje C, Midtvedt K, Reisæter AV.

Transplantation. 2014 Aug 27;98(4):e31. doi: 10.1097/TP.0000000000000330. No abstract available.

PMID:
25243517
50.

Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus.

Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisæter AV, Jenssen T.

Transplantation. 2015 Mar;99(3):629-35. doi: 10.1097/TP.0000000000000376.

PMID:
25162478

Supplemental Content

Loading ...
Support Center